Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 54992

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2024 | Month : April | Volume : 18 | Issue : 4 | Page : DC25 - DC29 Full Version

Clinico-bacteriological Study and Molecular Detection of Campylobacter in Childhood Diarrhoea: A Cross-sectional Study


Published: April 1, 2024 | DOI: https://doi.org/10.7860/JCDR/2024/68621.19292
Visakha Kadiyala, Madhuri Kulkarni, Prathyusha Kadiyala, Anshu Kumar Yadav

1. Associate Consultant, Department of Microbiology, Manipal Hospitals, Bengaluru, Karnataka, India. 2. Professor, Department of Microbiology, Al Azhar Institute of Medical Sciences and Research, Thodapuazha, Kerala, India. 3. Associate Professor, Department of Community Medicine, ACS Medical College and Hospital, Chennai, Tamil Nadu, India. 4. Tutor, Department of Biochemistry, JSS Medical College, Mysuru, Karnataka, India.

Correspondence Address :
Dr. Prathyusha Kadiyala,
Associate Professor, Department of Community Medicine, ACS Medical College and Hospital, Vellappanchavdi, Chennai-600077, Tamil Nadu, India.
E-mail: kadiyala.prathyusha@gmail.com

Abstract

Introduction: Campylobacter infections cause diarrhoeal diseases as frequently as Salmonella and Shigella infections. The prevalence of Campylobacter infection among children with acute diarrhoea in developing countries ranges from 5-35%. Diagnosing Campylobacter infections is challenging as the organism is difficult to isolate, grow, and identify. Currently, no best-practice clinical or public health laboratory guidelines exist for laboratory diagnosis of Campylobacter infections.

Aim: To explore the clinical and bacterial aspects of childhood diarrhoea, emphasising the prevalence and molecular detection of Campylobacter.

Materials and Methods: A hospital-based cross-sectional descriptive study was conducted with 55 stool samples of children under five with diarrhoea or dysentery at the Department of Microbiology, JSS Medical College, Mysuru, Karnataka, India, from October 2016 to September 2017. All stool samples were inoculated onto Campylobacter selective and non selective media with filtration and incubated in microaerophilic conditions. The culture isolates were identified by standard phenotypic tests. Molecular characterisation of Campylobacter was performed targeting the Campylobacter adhesion to fibronectin F (cadF) gene. The presence of a phylogenetically conserved 16S ribosomal Ribonucleic Acid (16SrRNA) domain was studied, followed by specific detection of pathogenic Campylobacter species. The Statistical Package for Social Sciences (SPSS) version 22.0 was used for statistical analysis. Descriptive statistics like percentage, mean, and Standard Deviation (SD) were applied.

Results: Campylobacter was isolated by culture in one out of 55 stool samples. The isolate was confirmed to be Campylobacter jejuni by phenotypic tests. Campylobacter genus-level Polymerase Chain Reaction (PCR) was positive for 6 samples (10.9%). Six positive samples were subjected to species-level PCR; all were positive for C. jejuni. Out of 55 stool samples, two diarrheagenic Escherichia coli, two Shigella sonnei, one Shigella dysenteriae, and one Salmonella enterica serovar Typhi were also identified.

Conclusion: Culture is insufficiently sensitive for diagnosing Campylobacter infection compared with nucleic acid-based diagnostics. Nucleic acid-based diagnostics offer increased sensitivity, can determine both the presence and burden of infection, and can distinguish between Campylobacter infections at the species level. Therefore, PCR is recommended, if feasible, as the preferred diagnostic modality for detecting Campylobacter infection.

Keywords

Campylobacter infection, Dysentery, Molecular diagnostic techniques

Diarrhoea is one of the most common diseases causing significant morbidity and mortality in children in developing countries. Diarrhoea is defined as the passage of abnormally liquid or unformed stools at an increased frequency. It is classified as acute if the duration is less than two weeks, persistent if lasting 2-4 weeks, and chronic if lasting more than four weeks (1). Diarrhoea significantly contributes to the high prevalence of malnutrition in young children, predisposing them to a vicious cycle of diarrhoea and malnutrition, making it a major public health problem (2).

Campylobacteriosis is a zoonotic disease observed in most parts of the world. It is rapidly becoming the most commonly recognised cause of bacterial gastroenteritis in humans, estimated to cause 5-14% of diarrhoea cases worldwide. Campylobacter infections are found to cause diarrhoeal disease 2-7 times more frequently than infections with Salmonella species and Shigella species, or are usually associated with Escherichia coli O157:H7 (3). The high incidence of Campylobacter diarrhoea, its duration, and possible sequelae make it highly important from a socio-economic perspective (4). In developing countries, Campylobacter jejuni is identified as one of the top five causes of diarrhoea among children aged 24-59 months, contributing significantly to the burden of diarrhoea. In India, C. jejuni was the third most common cause of diarrhoea in children aged 2-5 years, following rotavirus and Shigella (5). In South India, the prevalence of Campylobacter infections among children with diarrhoea was 4.5% (6).

Campylobacter is a Gram-negative curved, fastidious organism that requires a microaerophilic environment for growth. The optimum temperature for its growth is 30-37°C. The two species most commonly associated with human disease are C. jejuni and C. coli. Campylobacter jejuni accounts for over 80% of Campylobacter-related human illnesses, while C. coli accounts for 18.6% of human cases (7).

Campylobacter infection primarily occurs in infants, older people, and patients with underlying diseases (4). Symptoms include diarrhoea (sometimes bloody), nausea, abdominal pain, fever, headache, and vomiting. The incubation period is usually 2-5 days, with illness generally lasting 2-10 days. A unique feature of the disease is the severity of abdominal pain, which may become continuous and intense enough to mimic acute appendicitis (8). Campylobacter has four main virulence attributes: motility, adherence, invasion, and toxin production. The combination of its spiral shape and flagella allows for rapid motility, enabling the organisms to penetrate the intestinal lining, unlike other intestinal bacteria (9).

Campylobacter is diagnosed through direct microscopic examination to detect darting or tumbling motility of spiral rods by culturing faeces or rectal swabs on selective media. Enzyme immunoassay can also be used for diagnosis (10). Polymerase Chain Reaction (PCR) has high sensitivity in detecting Campylobacter and can distinguish between Campylobacter infections at the species level. Diagnosis can be challenging because the organism is difficult to isolate, grow, and identify. Direct plating onto Campylobacter selective medium, followed by incubation at 42°C under microaerobic conditions for 72 hours, has long been considered the gold standard for diagnosis (11).

Complications of Campylobacter infections occur due to direct spread from the gastrointestinal tract and can include cholecystitis, pancreatitis, peritonitis, and massive gastrointestinal haemorrhage (3). Bacteraemia can arise due to inadequate therapy; sometimes, sequelae can be seen in the form of Guillain-Barre syndrome and its variant, Miller-Fischer syndrome (4). Correction of electrolyte abnormalities and rehydration are the mainstays of treatment for Campylobacter enteritis. Antimicrobial therapy is recommended in invasive cases or to eliminate the carrier state (12). Erythromycin and Ciprofloxacin are the drugs of choice, but resistance to these drugs is increasing, especially in developing countries (13). It is necessary to detect Campylobacter from diarrhoeic stool to initiate prompt and appropriate antimicrobial therapy, which can reduce infection duration, severity, and complications (14).

Applying traditional laboratory methods and molecular techniques in identifying Campylobacter infections facilitates understanding the burden among under-five children, helping prevent unforeseen complications and mitigating antibiotic resistance by guiding judicious antibiotic use. Hence, the present study aimed to explore the clinical and bacterial aspects of childhood diarrhoea, emphasising the prevalence and molecular detection of Campylobacter. The primary objective is to estimate the prevalence of Campylobacter infections and investigate the clinical manifestations in under-five children. Secondary objectives are to compare Campylobacter culture and PCR results and to find out the association of different variables with Campylobacter gastroenteritis.

Material and Methods

A hospital-based cross-sectional descriptive study was conducted at Department of Microbiology, JSS Medical College, Mysuru, Karnataka, India, for one year (October 2016-September 2017). A structured questionnaire, which included the demographic data of the patient and the clinical history, was used. The study was approved by the JSS Medical College and Hospital Institutional Ethics Committee (letter No. JSSMC/PG/658/2015-16). A purposive sampling method was used, and informed consent was obtained from the parents/guardians accompanying the children before collecting their stool samples for the study. All procedures followed were in accordance with the ethical standards of the institutional committee on human experimentation and the Helsinki Declaration.

Inclusion and Exclusion criteria: Under-five children with acute diarrhoea or dysentery presented to the paediatrics department during the study period were included. Malnourished, immunocompromised children, and children on macrolides, quinolone, and prolonged steroids were excluded.

Sample size calculation: The required sample size of 48 was calculated using the formula (15) Z2*p*(1-p)/d2, where ‘Z’ represents the standard normal variable (1.96), p is a proportion based on a previous study conducted in Karnataka (16) (0.32), d is the absolute precision (5%), and a confidence level of 95%. Factoring in a non response rate of 7 (15%), the total sample size was determined to be 55.

Study Procedure

Sample collection and storage: Stool samples were collected in dry, sterile, leak-proof, wide-mouth containers. Most samples were processed immediately, while a few were stored at 2°C to 8°C and processed within 72 hours for Campylobacter culture. For PCR, stool samples were suspended in 1X Phosphate Buffered Saline (1X-PBS). Approximately 200 to 300 mg of stool sample was resuspended in 1 mL of 1X-PBS, thoroughly mixed to create a uniform stool suspension, and stored at -80°C in an ultra-low-temperature freezer (New Brunswick Scientific) until further processing.

Microscopy: Saline and iodine mounts were performed for faecal leukocytes, Red Blood Cells (RBCs), and motile bacteria to rule out parasitic causes. Gram’s staining was conducted on suspected samples (with characteristic motility or presence of thin curved/spiral forms) for the microscopic morphology of Campylobacter. Modified Gram’s stain with safranin counterstaining for ten minutes was utilised. Standard laboratory methods were adopted whenever other enteric pathogens were suspected on microscopy to isolate/identify them. Samples were inoculated onto one selective and one non selective medium. Two media were used simultaneously: the blood-free Campylobacter selective medium with supplement (Himedia, Mumbai, India) and 5% sheep blood agar (Himedia). Samples were inoculated after filtration through a 0.45 μm membrane filter (Himedia, Mumbai, India). The inoculated media were then incubated in a microaerophilic atmosphere using candle jars (Oxoid) at 37°C. In each 2.5 L capacity jar, seven plates of 90 mm diameter could be kept simultaneously, with five to six wax candles lit to create the microaerophilic atmosphere. A filtration method was also employed with non selective and selective media to enhance the recovery of Campylobacter. This was achieved by placing a filter (0.45 micrometers pore size, Himedia) on the agar surface and adding 2-3 drops of stool onto it. The plate was then incubated upright. After 60 minutes at 37°C, the filter was removed, and the plates were re-incubated in a microaerophilic atmosphere. As the organisms were motile and capable of migrating through the filter, they formed isolated colonies on the culture plates. Suspected colonies from the plates were checked by Gram’s stain (slender, curved, “gull-wing” shaped Gram-negative rod); a wet preparation of the organism was made for characteristic darting motility, oxidase, and catalase tests. Pseudomonas aeruginosa ATCC 9027 was used as a positive control for the oxidase test, and Staphylococcus aureus ATCC 25293 was used for the catalase test.

The same stool samples were simultaneously screened for other pathogens such as Salmonella, Shigella, Vibrio, Aeromonas, Diarrhoeagenic Escherichia coli, and intestinal parasites. For screening these pathogens, all stool samples were plated on selective media such as MacConkey’s agar, Xylose lactose deoxycholate, and Thiosulfate citrate bile salt agar. Identification was conducted using the Vitek system.

Molecular detection by Polymerase Chain Reaction (PCR): Briefly, 1 mL of uniformly mixed stool suspension was centrifuged at 600 Rotations Per Minute (rpm) for five minutes to pellet down coarse undigested materials. This was followed by the separation of the supernatant in a fresh sterile Microcentrifuge Tube (MCT), which was further centrifuged at 12,000 rpm for three minutes to sediment complete cellular fractions, including microbial cells. The cellular-rich pellet was washed with 1 mL of cold acetone (#MB179-500 mL, Himedia) to remove several dissolved inhibiting substances in the stool. It was then washed twice with 1 mL of 1X-Dulbecco’s Phosphate Buffered Saline (#TS1006-1L, Himedia) to remove excess acetone, including several chromogenic substances. The washed pellet was subjected to Deoxyribonucleic Acid (DNA) extraction using the HiPurA™ Stool DNA Purification kit (#MB544, Himedia), following the manufacturer’s protocol with slight modifications. The kit also contained a unique proprietary solution called Inhibitor Removal Solution (IRSH), which removes PCR inhibitory substances by precipitation during the early steps of extraction. The eluted DNA was further subjected to quantification and purity assessment using Nanodrop (DeNovix), followed by agarose gel electrophoresis to ensure the presence of good quality DNA for downstream applications.

The molecular analysis was conducted in three stages. The first stage of the molecular study involved the broad-range detection of the 16S ribosomal Deoxyribonucleic Acid (rDNA) gene as an internal control to validate the presence of pathogenic bacterial DNA in the sample extract. Negative results were excluded from the study as these samples did not present with bacterial DNA. Both positive and negative controls were included in the reaction. Pure clinical isolates of Campylobacter species (C. jejuni) were used as a positive control. Primers (U1/U2) for detecting a pathogenic group of bacteria were adopted from Lu JJ et al., and procured from Eurofins genomics. The primer sequences included U1: 5’- CCAGCAGCCGCGGTAATACG-3’ and U2: 5’-ATCGG(C/T)TACCTTGTTACGACTTC-3’ (17).

The 2nd stage of the molecular study involved the universal detection of Campylobacter species using a universal primer mix, and the 3rd stage included the characterisation of Campylobacter universal positive samples into two pathogenic species associated with gastrointestinal pathologies, including C. jejuni and C. coli. Both universal and species-specific primer mixes were procured from Helini Biomolecules along with their respective positive controls. A putative virulence determinant, cadF (Campylobacter adhesion to fibronectin F) gene, was targeted for designing primers for C. jejuni and C. coli. This gene encodes an adhesion and fibronectin-binding protein involved in the invasion process, thereby influencing microfilament organisation in host cells (18).

The PCR reaction was carried out in a 30 μL volume, including 1X PCR buffer (#M0273S, NEB) containing 10 mM Tris-HCl (pH 8.8 at 25°C), 1.5 mM MgCl2, 50 mM KCl, 0.1% Triton X-100, dNTPs mix (0.5 mM), MgCl2 (0.5 mM), BSA 0.8 mg/mL (#SH30574.20, HyClone), Taq DNA polymerase 1U (#M0273S, NEB). The primer concentrations included 0.01 μM (16S rDNA) and 0.3 μM (Campylobacter) in each PCR reaction. Finally, 3 μL of a sample or respective control was added. Gradient PCR was performed (Mastercycler gradient, Eppendorf) to standardise PCR conditions, especially primer annealing. The common PCR conditions for all target genes amplification included initial denaturation at 95°C for five minutes, followed by 35 cycles of denaturation (95°C, 45 seconds), annealing (58°C, 45 seconds), and extension (72°C, 45 seconds), which was followed by a final extension at 72°C for five minutes. Post-PCR products were resolved on a 2.5% agarose gel with ethidium bromide (10 mg/mL) using electrophoresis at 50V. Finally, DNA bands were visualised using the gel documentation unit (exposure time eight seconds in TLUM mid-wave photo mode). Results were analysed based on the presence or absence of specific amplicons with product sizes of 996 bp (16S rDNA), 330 bp (Campylobacter universal), 335 bp (Campylobacter jejuni), and 365 bp (Campylobacter coli). A 100 bp DNA size marker was included to estimate the size of the PCR products. Confirmation of PCR products by Sanger’s sequencing: PCR products from representative samples were subjected to column purification using the QIA quick PCR Purification Kit (#28104, Qiagen). Further, purified PCR products were subjected to cycle sequencing using dye terminator chemistry, i.e., BigDye Terminator v3.1 and Polymer POP7. Forward and reverse reactions were carried out in separate reactions using respective primers. Sanger’s sequencing (ABI3730XL-96, Applied-Biosystems) was employed, and the respective chromatogram was developed. Finally, nucleotide sequences were aligned with the respective bacterial genome database available in the NCBI gene bank, using multiple sequence alignment tools, i.e., Clustal Omega software. All products for both forward and reverse sequenced reactions found 99-100% homologies with the expected targets, i.e., Campylobacter species, with an E (Expected) value near to zero, which confirmed the source of the DNA sample as Campylobacter in the given stool sample.

Statistical Analysis

The data entry and statistical analysis were done using Microsoft excel and SPSS version 22.0. Descriptive statistics like percentage, mean, and standard deviation were applied. The Chi-square test was applied to find the association between variables and Campylobacter gastroenteritis. Fisher’s exact test was applied where 20% of expected values were less than 5. A significant association was considered at p<0.05.

Results

Among the 55 stool samples of under-five children who presented with complaints of diarrhoea, dysentery, and acute gastroenteritis were included. Among the study participants, 23 (41.82%) were infants, 13 (23.64%) belonged to the age group of 12-24 months, and the remaining 19 (34.54%) belonged to 24-60 months. Out of the 55 under-five children, 35 (63.6%) were males and 20 (36.4%) were females. Of the 55 children, 12 presented with only diarrhoea, 26 with diarrhoea and fever, and 17 with diarrhoea and other symptoms such as vomiting, abdominal pain, and febrile seizures. Among the study participants, 17 (30.9%) were clinically diagnosed with acute gastroenteritis with no dehydration, 12 (21.81%) with acute gastroenteritis with some dehydration, 9 (16.36%) with pyrexia of unknown origin, 8 (14.55%) with dengue fever, 5 (9.09%) with respiratory infections, 2 (3.64%) with bacillary dysentery, and 2 (3.64%) with viral fevers. Among the 55 study subjects, 39 (70.9%) were on antibiotics such as Cephalosporins and Betalactam-beta-lactamase inhibitor combinations, while 16 (29.09%) were not on antibiotics at the time of sample collection. Out of the 55 patients, 2 (3.64%) had a history of animal exposure, while the rest had no history of animal exposure. Stool macroscopy revealed the presence of mucus in 28 (50.9%) and blood in 2 (3.6%) stool samples. Stool consistency was liquid in 34 (61.8%) and semisolid in 21 (38.2%) samples. On stool microscopy, 16 (29.1%) samples were normal, 30 (54.5%) had inflammatory cells, and 9 (16.4%) had both red blood cells and inflammatory cells. Out of the 55 stool samples, six other intestinal pathogens and one Campylobacter were isolated by culture. Among the six pathogens, two were Diarrheagenic Escherichia coli, two were Shigella sonnei, one was Shigella dysenteriae, and one was Salmonella Typhi. Among the 55 stool samples, Campylobacter culture was positive in only one sample. Suspected tiny grey-coloured colonies on a selective medium were phenotypically identified as Campylobacter by Gram stain morphology, characteristic motility, oxidase, and catalase tests. Genomic DNA isolation using a spin column-based method yielded intact DNA bands from all 55 stool samples when observed after electrophoresis. Further DNA purity assessment was found to be within the acceptable limit (260/280 ratio: 1.6-1.9) when analysed using nanodrop. The PCR result revealed successful amplification of 16S rDNA from all 55 samples with an expected band size of 996 bp. The presence of the 16S rDNA band validated the source of DNA as a bacterial population. Further, these bacterial positive DNA samples were studied for the presence of Campylobacter-specific genes. Six (10.9%) samples were identified as positive cases for Campylobacter out of the 55 clinically suspected samples (Table/Fig 1).

Campylobacter-positive samples were finally subjected to species identification. All six Campylobacter-positive samples showed the presence of C. jejuni, and none showed the presence of C. coli, neither as a pure isolate nor as a mixed isolate with C. jejuni, indicating that C. jejuni is solely responsible for the enteric pathology associated with Campylobacteriosis among the study population (Table/Fig 2). In the present study, no statistically significant association was found between various factors (gender, age, exposure to antibiotics, exposure to animals) and PCR results. However, the prevalence of Campylobacter infection was higher in children clinically diagnosed with acute gastroenteritis with some dehydration (4, 33.3%) compared to other clinical diagnosis, and this difference was found to be statistically significant (p-value=0.036) as shown in (Table/Fig 3).

Discussion

In the present study, the prevalence of Campylobacter infections accounts for 10.9% of acute diarrhoeal diseases among under-five children. Studies from Asia show a 17.7% isolation rate from Bangladesh (19), 8% from Tehran (14), 18% from Rawalpindi (20), and several studies from India showed varying ranges from 7% to 18% (21),(22),(23),(24). Studies have found the prevalence of Campylobacteriosis (C. jejuni/C. coli) in India during 2003-2010 to be 5-16% of gastroenteritis cases (6),(21). C. jejuni and C. coli rapidly became the most commonly recognised cause of bacterial gastroenteritis, causing 5-14% of diarrhoea worldwide (3).

Campylobacter mostly affects children. In the present study, most children suffering from Campylobacter-associated diarrhoea were less than 48 months of age. The maximum age group of children from which Campylobacter could be isolated in the present study was four years, while the minimum was 17 months. A study in China showed the peak incidence to be between 12 and 24 months of age (25). In another study conducted in Rawalpindi (20), the maximum and minimum age of isolation were 48 months and three months, respectively. In Bangladesh, the maximum isolation rate was noted in children between 12 and 24 months (19). A study from Ranchi (22) showed that the maximum isolation was in children below the age of six years and below four years of age from a study in Puducherry (23), while another study from Vellore (24) showed that the maximum rate of isolation was from preschool children. In studies conducted in Bijapur, Gulbarga, and Kolkata, the isolation was found more in the under-five age group (16),(21). The present study findings are similar to these studies and complement the prevailing age distribution pattern, which could be due to the combined effects of declining levels of maternally acquired antibodies and the weaning of the children. This emphasises that clinicians should suspect Campylobacter as a cause of diarrhoea in children under the age of five. In the present study, C. jejuni was detected in 4 (11.4%) male children and 2 (10%) female children (Table/Fig 3). Gender distribution did not show any statistical significance. Similarly, no difference in sex distribution was noted in studies conducted in Puducherry (23) and Vellore (6). On the contrary, a study done in Taiwan (26) showed a statistically significant difference in gender in the prevalence of Campylobacter enteritis.

Out of 55 stool samples, one (2%) yielded Campylobacter on culture, and 6 (10.9%) were positive by PCR. This finding indicates that culture is not as sensitive as PCR for diagnosing Campylobacter infection in the present settings. Similar findings were shown in a study conducted in France (27), where out of 23 Campylobacters, only 16 were detected by culture, and PCR detected all. A multisite longitudinal study of enteric infections in Tanzania, Bangladesh, and Peru (28) found substantial under-detection of Campylobacter by selective culture compared to detection levels by both enzyme immunoassays and PCR. This indicates the limited sensitivity of culture compared to molecular methods in general. A study conducted in Kolkata found that molecular methods detected more infections with Campylobacter spp. than culture (21). On the contrary, a study conducted in Puducherry states that culture was as sensitive as PCR (23).

In the present study, the prevalence of Campylobacter infections accounts for 10.9% of acute diarrhoeal diseases among under-five children. Studies from Asia show a 17.7% isolation rate from Bangladesh (19), 8% from Tehran (14), 18% from Rawalpindi (20), and several studies from India showed varying ranges from 7% to 18% (21),(22),(23),(24). Studies have found the prevalence of Campylobacteriosis (C. jejuni/C. coli) in India during 2003-2010 to be 5-16% of gastroenteritis cases [6,21]. C. jejuni and C. coli rapidly became the most commonly recognised cause of bacterial gastroenteritis, causing 5-14% of diarrhoea worldwide (3).

Campylobacter mostly affects children. In the present study, most children suffering from Campylobacter-associated diarrhoea were less than 48 months of age. The maximum age group of children from which Campylobacter could be isolated in the present study was four years, while the minimum was 17 months. A study in China showed the peak incidence to be between 12 and 24 months of age (25). In another study conducted in Rawalpindi (20), the maximum and minimum age of isolation were 48 months and three months, respectively. In Bangladesh, the maximum isolation rate was noted in children between 12 and 24 months (19). A study from Ranchi (22) showed that the maximum isolation was in children below the age of six years and below four years of age from a study in Puducherry (23), while another study from Vellore (24) showed that the maximum rate of isolation was from preschool children. In studies conducted in Bijapur, Gulbarga, and Kolkata, the isolation was found more in the under-five age group (16),(21). The present study findings are similar to these studies and complement the prevailing age distribution pattern, which could be due to the combined effects of declining levels of maternally acquired antibodies and the weaning of the children. This emphasises that clinicians should suspect Campylobacter as a cause of diarrhoea in children under the age of five. In the present study, C. jejuni was detected in 4 (11.4%) male children and 2 (10%) female children (Table/Fig 3). Gender distribution did not show any statistical significance. Similarly, no difference in sex distribution was noted in studies conducted in Puducherry (23) and Vellore (6). On the contrary, a study done in Taiwan (26) showed a statistically significant difference in gender in the prevalence of Campylobacter enteritis.

Out of 55 stool samples, one (2%) yielded Campylobacter on culture, and 6 (10.9%) were positive by PCR. This finding indicates that culture is not as sensitive as PCR for diagnosing Campylobacter infection in the present settings. Similar findings were shown in a study conducted in France (27), where out of 23 Campylobacters, only 16 were detected by culture, and PCR detected all. A multisite longitudinal study of enteric infections in Tanzania, Bangladesh, and Peru (28) found substantial under-detection of Campylobacter by selective culture compared to detection levels by both enzyme immunoassays and PCR. This indicates the limited sensitivity of culture compared to molecular methods in general. A study conducted in Kolkata found that molecular methods detected more infections with Campylobacter spp. than culture (21). On the contrary, a study conducted in Puducherry states that culture was as sensitive as PCR (23).

Limitation(s)

Due to logistic constraints, the study could not include antibiotic susceptibility testing and the detection of drug resistance in Campylobacter species, and screening for viruses was not done.

Conclusion

It is crucial to include the diagnosis of Campylobacter infection in routine examinations for children with acute diarrhoea, as these infections are more prevalent than commonly perceived. Culture is insufficiently sensitive for diagnosing Campylobacter infection compared with nucleic acid-based diagnostics. Therefore, PCR is recommended, if feasible, as the preferred diagnostic modality for detecting Campylobacter infection in children with acute diarrhoea in developing countries. Precise diagnosis guides judicious antibiotic use and mitigates the risk of antibiotic resistance.

Declaration: The present study was previously presented as a meeting abstract at the International Meeting on Emerging Diseases and Surveillance (IMED), held in Vienna, Austria on November 10, 2018. https://doi. org/10.1016/j.ijid.2018.11.220.

References

1.
Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Diarrhoea and constipation. In: Eugene Braunwald, MD; Anthony S. Fauci, MD; Dennis L, editors. Harrison’s Principles of Internal Medicine. 19th ed. New York: McGraw Hill; 2015. Pp. 265-68.
2.
Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ. 2003;81(3):197-204. Available from: https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC2572419/.
3.
Allos BM. Campylobacter jejuni infections: Update on emerging issues and trends. Clinical Infectious Diseases. 2001;32(8):1201-06. Available from: https://dx.doi. org/10.1086/319760?utm_medium=email&utm_source=transaction. [crossref][PubMed]
4.
Floch P, Goret J, Bessède E, Lehours P, Mégraud F. Evaluation of the positive predictive value of a rapid immunochromatographic test to detect Campylobacter in stools. Gut Pathogens. 2012;4(1):01-03. Available from: https://dx.doi.org/ 10.1186/1757-4749-4-17?utm_medium=email&utm_source=transaction. [crossref][PubMed]
5.
Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): A prospective, case-control study. The Lancet. 2013;382(9888):209-22. Available from: https:// doi.org/10.1016/S0140-6736(13)60844-2.
6.
Rajendran P, Babji S, George AT, Rajan DP, Kang G, Ajjampur SS. Detection and species identification of Campylobacter in stool samples of children and animals from Vellore, south India. Indian J Med Microbio. 2012;30(1):85-88. Available from: https://doi.org/10.4103/0255-0857.93049. [crossref][PubMed]
7.
Nachamkin I. Campylobacter jejuni. In: Doyle, MP, Beuchat LR, editors. Food microbiology: Fundamentals and frontiers. 3rd ed. Washington DC: ASM Press; 2007. Pp. 237-48. [crossref]
8.
Steven Foley. Campylobacter jejuni. In: Keith A. Lampel, editor. Bad bug book: Foodborne pathogenic microorganisms and natural toxins handbook. 2nd ed. Silver Spring: US Food and Drug Administration; 2012. Pp.17-20. Available from: https://www.fda.gov/media/83271/download.
9.
Levin RE. Campylobacter jejuni: A review of its characteristics, pathogenicity, ecology, distribution, subspecies characterization and molecular methods of detection. Food Biotechnology. 2007;21(4):271-347. Available from: https://doi. org/10.1080/08905430701536565. [crossref]
10.
Ananthanarayan R. Jayaram Paniker CK. Miscellaneous bacteria. In: Reba Kanungo, editor. Ananthanarayan and Paniker’s Textbook of Microbiology. 10th ed. Hyderabad: Universities Press Private; 2017. Pp. 406.
11.
Fitzgerald C, Nachamkin I. Campylobacter and arcobacter. In: Jorgensen JH, Carroll KC, Funke G, Pfaller MA, Landry ML, Richter SS, Warnock DW, editors. Manual of clinical microbiology. 11th ed. ASM Press; 2015 May. Pp. 998-1012. [crossref]
12.
World Health Organization. May 2020. Campylobacter Fact Sheet No.255. Available from: https://www.who.int/news-room/fact-sheets/detail/Campylobacter.
13.
Coker AO, Isokpehi RD, Thomas BN, Amisu KO, Obi CL. Human campylobacteriosis in developing countries. Emerg Infect Dis. 2002;8(3):237-44. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732465/. [crossref][PubMed]
14.
Feizabadi MM, Dolatabadi S, Zali MR. Isolation and drug-resistant patterns of Campylobacter strains cultured from diarrhoeic children in Tehran. Japanese Journal of Infectious Diseases. 2007;60(4):217-19. Available from: https://www. niid.go.jp/niid/JJID/60/217.pdf. [crossref][PubMed]
15.
Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35(2):121-26. Available from: https://doi.org/10.4103/0253-7176.116232. [crossref][PubMed]
16.
Naik DG, Jayaraj YM. Campylobacter jejuni diarrhoea in north Karnataka. Indian Pediatr. 1998;35(8):768-70. Available from: https://pesquisa.bvsalud.org/portal/ resource/pt/sea-6624.
17.
Lu JJ, Perng CL, Lee SY, Wan CC. Use of PCR with universal primers and restriction endonuclease digestions for detection and identification of common bacterial pathogens in cerebrospinal fluid. J Clin Microbiol. 2000;38(6):2076-80. Available from: https://doi.org/10.1128/jcm.38.6.2076-2080.2000. [crossref][PubMed]
18.
Bolton DJ. Campylobacter virulence and survival factors. Food Microbiology. 2015;48:99-108. Available from: https://doi.org/10.1016/j.fm.2014.11.017. [crossref][PubMed]
19.
Blaser MJ, Glass RI, Huq MI, Stoll B, Kibriya GM, Alim AR. Isolation of Campylobacter fetus subsp. jejuni from Bangladeshi children. J Clin Microbiol. 1980;12(6):744-47. Available from: https://doi.org/10.1128/jcm.12.6.744-747.1980. [crossref][PubMed]
20.
Ali AM, Qureshi AH, Rafi S, Roshan E, Khan I, Malik AM, et al. Frequency of Campylobacter jejuni in diarrhoea/dysentery in children in Rawalpindi and Islamabad. J Pak Med Assoc. 2003;53(11):517-20. Available from: https:// europepmc.org/article/med/14738256.
21.
Mukherjee P, Ramamurthy T, Bhattacharya MK, Rajendran K, Mukhopadhyay AK. Campylobacter jejuni in hospitalized patients with diarrhoea, Kolkata, India. Emerg Infect Dis. 2013;19(7):1155-56. Available from: https://doi.org/ 10.3201%2Feid1907.121278. [crossref][PubMed]
22.
Rizal A, Kumar A, Vidyarthi AS. Prevalence of pathogenic genes in Campylobacter jejuni isolated from poultry and human. Internet Journal of Food Safety. 2010;12:29- 34. Available from: https://www.researchgate.net/profile/Ambarish-Vidyarthi/ publication/242671054_Prevalence_of_Pathogenic_Genes_in_Campylobacter_ jejuni_Isolated_from_Poultry_and_Human/links/570e32ad08aec783ddd1b805/ Prevalence-of-Pathogenic-Genes-in-Campylobacter-jejuni-Isolated-from- Poultry-and-Human.pdf.
23.
Salim SM, Mandal J, Parija SC. Isolation of Campylobacter from human stool samples. Indian J Med Microbio. 2014;32(1):35-38. Available from: https://doi. org/10.4103/0255-0857.124294. [crossref][PubMed]
24.
Rajan DP, Mathan VI. Prevalence of Campylobacter fetus subsp. jejuni in healthy populations in southern India. J Clin Microbiol. 1982;15(5):749-51. Available from: https://doi.org/10.1128/jcm.15.5.749-751.1982. [crossref][PubMed]
25.
Desheng L, Zhixin C, Bolun W. Age distribution of diarrhoeal and healthy children infected with Campylobacter jejuni. J Trop Med Hyg. 1992;95(3):218-20. Available from: https://europepmc.org/article/med/1597881.
26.
Lin CW, Yin PL, Cheng KS. Incidence and clinical manifestations of Campylobacter enteritis in central Taiwan. Zhonghua Yi Xue Za Zhi (Taipei). 1998;61(6):339-45. Available from: https://europepmc.org/article/med/9684510.
27.
Bessede E, Delcamp A, Sifré E, Buissonnière A, Mégraud F. New methods for detection of Campylobacters in stool samples in comparison to Culture. J Clin Microbiol. 2011;49(3):941-44. Available from: https://doi.org/10.1128/jcm.01489-10. [crossref][PubMed]
28.
Platts-Mills JA, Liu J, Gratz J, Mduma E, Amour C, Swai N, et al. Detection of Campylobacter in stool and determination of significance by Culture, enzyme immunoassay, and PCR in developing countries. J Clin Microbiol. 2014;52(4):1074-80. Available from: https://doi.org/10.1128/jcm.02935-13. [crossref][PubMed]
29.
Vaishnavi C, Singh M, Thakur JS, Thapa BR. Low prevalence of Campylobacteriosis in the Northern region of India. Advances in Microbiology. 2015;5(03):155-65. Available from: http://dx.doi.org/10.4236/aim.2015.53015. [crossref]
30.
Saeed AM, Harris NV, DiGiacomo RF. The role of exposure to animals in the etiology of Campylobacter jejuni/coli enteritis. Am J Epidemiol. 1993;137(1):108- 14. Available from: https://doi.org/10.1093/oxfordjournals.aje.a116592.[crossref][PubMed]

DOI and Others

DOI: 10.7860/JCDR/2024/68621.19292

Date of Submission: Nov 17, 2023
Date of Peer Review: Dec 21, 2023
Date of Acceptance: Feb 16, 2024
Date of Publishing: Apr 01, 2024

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Nov 20, 2023
• Manual Googling: Jan 05, 2024
• iThenticate Software: Feb 14, 2024 (9%)

ETYMOLOGY: Author Origin

EMENDATIONS: 6

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com